Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0018799 (heart disease)
 34,133 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Intracellular microelectrodes were used to study the electrophysiological effects on action and resting potentials, refractory periods and conduction velocities of four contrast media administered either as 1/100 and 1/1000 solutions or as 20 mg bolus injections. The products studied were Telebrix, which has high osmolality (2100 mOsm/kg) and three other contrast media with lower osmolatity (700 mOsm/kg), including Hexabrix, which contains sodium, and Iopamidol and Iohexol which are sodium-free. The parameters measured were not modified by Hexabrix and Telebrix, whereas Omnipaque and Iopamiron induced varied and significant changes in these parameters, notably in concentrations of 1/100 and as bolus injections. It is suggested that the latter contrast media should be used in non-cardiovascular explorations and in patients without confirmed heart disease.
 ...
PMID:[Intracellular microelectrode study of the electrophysiological effects of contrast media]. 314 53

Sixty-two children investigated by cardiac angiography for a wide spectrum of congenital heart disease were randomly assigned to one of two groups, one for iohexol, 350 mg I/ml (Omnipaque, Nycomed UK Ltd) and one for iopamidol, 370 mg I/ml (Niopam, E. Merck Ltd). Changes in systolic pressure, end-diastolic pressure when the injection was made into a ventricle, heart rate and rhythm and plasma osmolality were assessed at 1 min and 3 min after the injection of contrast medium. The angiograms were subjectively assessed for angiographic quality. No significant differences were detected between the two groups.
 ...
PMID:Comparison of low-osmolar contrast media in paediatric cardiac angiography. 381 9

A nonionic contrast medium (iohexol) was evaluated for safety and efficacy in pediatric angiocardiography in this study of 15 patients, age 6 to 82 months. Patients carried a preliminary diagnosis of congenital heart disease. Subjects were injected with iohexol, 350 mg iodine/ml of solution with an average volume of 2.46 ml/kg of body weight at a rate of 9 to 14.5 ml/sec. The parameters evaluated included vital signs, intravascular BP, ECG changes, discomfort, and adverse reactions. No adverse reactions were noted in 14 of 15 patients. No significant changes in axillary temperature of ECG were observed. Intravascular blood pressure showed only moderate changes. After 24 hours, creatine phosphokinase (CPK) plasma concentrations increased significantly. Serum electrolytes remained unchanged. Image quality was deemed excellent considering variations in injection site and flow condition of the heart. Iohexol caused remarkably little discomfort and no adverse effects.
 ...
PMID:Pediatric angiocardiography with iohexol. 397 30

The effects of right atrial injections of Renografin 76 (meglumine diatrizoate), hypertonic (5%) sodium chloride, and iohexol, a new nonionic contrast medium, on sequential measures of left atrial pressure and extravascular lung water in anesthetized dogs were studied. Renografin 76 caused significant transient elevations of extravascular lung water; control levels were reestablished at 15-20 minutes after injection. These changes occurred in the absence of significant changes in left atrial pressure. Iohexol reduced extravascular lung water slightly while hypertonic saline transiently increased it. The increased extravascular lung water after right atrial injections of ionic contrast medium can only partially be explained by the tonicity of the medium. This increase was not observed with nonionic medium, suggesting that nonionic media may be preferable imaging agents in patients with underlying lung or heart disease, and may be more suitable for digital intravenous examinations.
 ...
PMID:Extravascular lung water: effects of ionic and nonionic contrast media. 662 79